From metabolomics to fluxomics: A computational procedure to translate metabolite profiles into metabolic fluxes

Sonia Cortassa, Viviane Caceres, Lauren N. Bell, Brian O'Rourke, Nazareno Paolocci, Miguel A. Aon

Research output: Contribution to journalArticle

Abstract

We describe a believed-novel procedure for translating metabolite profiles (metabolome) into the set of metabolic fluxes (fluxome) from which they originated. Methodologically, computational modeling is integrated with an analytical platform comprising linear optimization, continuation and dynamic analyses, and metabolic control. The procedure was tested with metabolite profiles obtained from ex vivo mice Langendorff-heart preparations perfused with glucose. The metabolic profiles were analyzed using a detailed kinetic model of the glucose catabolic pathways including glycolysis, pentose phosphate (PP), glycogenolysis, and polyols to translate the glucose metabolome of the heart into the fluxome. After optimization, the ability of the model to simulate the initial metabolite profile was confirmed, and metabolic fluxes as well as the structure of control and regulation of the glucose catabolic network could be calculated. We show that the step catalyzed by phosphofructokinase together with ATP demand and glycogenolysis exert the highest control on the glycolytic flux. The negative flux control exerted by phosphofructokinase on the PP and polyol pathways revealed that the extent of glycolytic flux directly affects flux redirection through these pathways, i.e., the higher the glycolytic flux the lower the PP and polyols. This believed-novel methodological approach represents a step forward that may help in designing therapeutic strategies targeted to diagnose, prevent, and treat metabolic diseases.

Original languageEnglish (US)
Pages (from-to)163-172
Number of pages10
JournalBiophysical Journal
Volume108
Issue number1
DOIs
StatePublished - Jan 6 2015

Fingerprint

Metabolomics
Metabolome
Pentoses
Glycogenolysis
Glucose
Phosphofructokinases
Phosphates
Pentose Phosphate Pathway
Metabolic Diseases
Glycolysis
Adenosine Triphosphate
polyol
Therapeutics

ASJC Scopus subject areas

  • Biophysics

Cite this

From metabolomics to fluxomics : A computational procedure to translate metabolite profiles into metabolic fluxes. / Cortassa, Sonia; Caceres, Viviane; Bell, Lauren N.; O'Rourke, Brian; Paolocci, Nazareno; Aon, Miguel A.

In: Biophysical Journal, Vol. 108, No. 1, 06.01.2015, p. 163-172.

Research output: Contribution to journalArticle

Cortassa, Sonia ; Caceres, Viviane ; Bell, Lauren N. ; O'Rourke, Brian ; Paolocci, Nazareno ; Aon, Miguel A. / From metabolomics to fluxomics : A computational procedure to translate metabolite profiles into metabolic fluxes. In: Biophysical Journal. 2015 ; Vol. 108, No. 1. pp. 163-172.
@article{8a55f63345b94b5280c7fdb0d7a42a73,
title = "From metabolomics to fluxomics: A computational procedure to translate metabolite profiles into metabolic fluxes",
abstract = "We describe a believed-novel procedure for translating metabolite profiles (metabolome) into the set of metabolic fluxes (fluxome) from which they originated. Methodologically, computational modeling is integrated with an analytical platform comprising linear optimization, continuation and dynamic analyses, and metabolic control. The procedure was tested with metabolite profiles obtained from ex vivo mice Langendorff-heart preparations perfused with glucose. The metabolic profiles were analyzed using a detailed kinetic model of the glucose catabolic pathways including glycolysis, pentose phosphate (PP), glycogenolysis, and polyols to translate the glucose metabolome of the heart into the fluxome. After optimization, the ability of the model to simulate the initial metabolite profile was confirmed, and metabolic fluxes as well as the structure of control and regulation of the glucose catabolic network could be calculated. We show that the step catalyzed by phosphofructokinase together with ATP demand and glycogenolysis exert the highest control on the glycolytic flux. The negative flux control exerted by phosphofructokinase on the PP and polyol pathways revealed that the extent of glycolytic flux directly affects flux redirection through these pathways, i.e., the higher the glycolytic flux the lower the PP and polyols. This believed-novel methodological approach represents a step forward that may help in designing therapeutic strategies targeted to diagnose, prevent, and treat metabolic diseases.",
author = "Sonia Cortassa and Viviane Caceres and Bell, {Lauren N.} and Brian O'Rourke and Nazareno Paolocci and Aon, {Miguel A.}",
year = "2015",
month = "1",
day = "6",
doi = "10.1016/j.bpj.2014.11.1857",
language = "English (US)",
volume = "108",
pages = "163--172",
journal = "Biophysical Journal",
issn = "0006-3495",
publisher = "Biophysical Society",
number = "1",

}

TY - JOUR

T1 - From metabolomics to fluxomics

T2 - A computational procedure to translate metabolite profiles into metabolic fluxes

AU - Cortassa, Sonia

AU - Caceres, Viviane

AU - Bell, Lauren N.

AU - O'Rourke, Brian

AU - Paolocci, Nazareno

AU - Aon, Miguel A.

PY - 2015/1/6

Y1 - 2015/1/6

N2 - We describe a believed-novel procedure for translating metabolite profiles (metabolome) into the set of metabolic fluxes (fluxome) from which they originated. Methodologically, computational modeling is integrated with an analytical platform comprising linear optimization, continuation and dynamic analyses, and metabolic control. The procedure was tested with metabolite profiles obtained from ex vivo mice Langendorff-heart preparations perfused with glucose. The metabolic profiles were analyzed using a detailed kinetic model of the glucose catabolic pathways including glycolysis, pentose phosphate (PP), glycogenolysis, and polyols to translate the glucose metabolome of the heart into the fluxome. After optimization, the ability of the model to simulate the initial metabolite profile was confirmed, and metabolic fluxes as well as the structure of control and regulation of the glucose catabolic network could be calculated. We show that the step catalyzed by phosphofructokinase together with ATP demand and glycogenolysis exert the highest control on the glycolytic flux. The negative flux control exerted by phosphofructokinase on the PP and polyol pathways revealed that the extent of glycolytic flux directly affects flux redirection through these pathways, i.e., the higher the glycolytic flux the lower the PP and polyols. This believed-novel methodological approach represents a step forward that may help in designing therapeutic strategies targeted to diagnose, prevent, and treat metabolic diseases.

AB - We describe a believed-novel procedure for translating metabolite profiles (metabolome) into the set of metabolic fluxes (fluxome) from which they originated. Methodologically, computational modeling is integrated with an analytical platform comprising linear optimization, continuation and dynamic analyses, and metabolic control. The procedure was tested with metabolite profiles obtained from ex vivo mice Langendorff-heart preparations perfused with glucose. The metabolic profiles were analyzed using a detailed kinetic model of the glucose catabolic pathways including glycolysis, pentose phosphate (PP), glycogenolysis, and polyols to translate the glucose metabolome of the heart into the fluxome. After optimization, the ability of the model to simulate the initial metabolite profile was confirmed, and metabolic fluxes as well as the structure of control and regulation of the glucose catabolic network could be calculated. We show that the step catalyzed by phosphofructokinase together with ATP demand and glycogenolysis exert the highest control on the glycolytic flux. The negative flux control exerted by phosphofructokinase on the PP and polyol pathways revealed that the extent of glycolytic flux directly affects flux redirection through these pathways, i.e., the higher the glycolytic flux the lower the PP and polyols. This believed-novel methodological approach represents a step forward that may help in designing therapeutic strategies targeted to diagnose, prevent, and treat metabolic diseases.

UR - http://www.scopus.com/inward/record.url?scp=84920997181&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920997181&partnerID=8YFLogxK

U2 - 10.1016/j.bpj.2014.11.1857

DO - 10.1016/j.bpj.2014.11.1857

M3 - Article

C2 - 25564863

AN - SCOPUS:84920997181

VL - 108

SP - 163

EP - 172

JO - Biophysical Journal

JF - Biophysical Journal

SN - 0006-3495

IS - 1

ER -